Hydrogel device enables painless transdermal delivery of nucleic acids for cancer immunotherapy

Hydrogel device enables painless transdermal delivery of nucleic acids for cancer immunotherapy

Nucleic acid (NA)-based medicine has been a focal point of research over the past two decades and has shown immense promise for both therapeutics and vaccines. The rapid development and deployment of NA-based vaccines during the COVID-19 pandemic underscored their potential.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *